Featured Press Releases

Stealth BioTherapeutics announces an FDA advisory committee meeting to review Elamipretide for Barth syndrome treatment

Stealth BioTherapeutics announces an FDA advisory committee meeting to review Elamipretide for Barth syndrome treatment

Pilatus Biosciences Inc. earns FDA Orphan Drug Designation for PLT012, targeting liver and intrahepatic bile duct cancer

Pilatus Biosciences Inc. earns FDA Orphan Drug Designation for PLT012, targeting liver and intrahepatic bile duct cancer

  • 10 Dec 2024

Pilatus Biosciences Inc. announced that the U.S. Food and Drug Administration (FDA) has granted...

Merz Aesthetics launches Ultherapy PRIME, the next generation of nonsurgical skin lifting treatments

Merz Aesthetics launches Ultherapy PRIME, the next generation of nonsurgical skin lifting treatments

Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA, according to Currax Pharmaceuticals

Peer-Reviewed Study in Obesity Pillars Further Substantiates Cardiovascular Safety Profile of CONTRAVE®/MYSIMBA, according to Currax Pharmaceuticals

Carterra unveils Carterra Ultra™, its most sensitive biosensor platform, advancing fragment and small molecule drug discovery

Carterra unveils Carterra Ultra™, its most sensitive biosensor platform, advancing fragment and small molecule drug discovery

Secretome Therapeutics

Secretome Therapeutics' STM-01, a neonatal cardiac progenitor cell therapy for HFpEF, receives FDA Fast Track designation

Fast Company recognizes Bruin Biometrics as a top 10 innovative medical device maker

Fast Company recognizes Bruin Biometrics as a top 10 innovative medical device maker

  • Bruin Biometrics, LLC
  • 25 Mar 2025
Medline to launch a synthetic ligament augmentation implant.

Medline to launch a synthetic ligament augmentation implant.

  • Medline Industries, LP
  • 24 Mar 2025
Pint Pharma secures ANVISA approval for BESREMi® to treat Polycythemia Vera

Pint Pharma secures ANVISA approval for BESREMi® to treat Polycythemia Vera

  • Pint Pharma
  • 24 Mar 2025
Secretome Therapeutics

Secretome Therapeutics' STM-01, a neonatal cardiac progenitor cell therapy for HFpEF, receives FDA Fast Track designation

  • Secretome Therapeutics
  • 23 Mar 2025
Developing innovative production technology for the commercialization of 3D cell products, PHC and Cyfuse collaborate

Developing innovative production technology for the commercialization of 3D cell products, PHC and Cyfuse collaborate

  • PHC Corporation
  • 20 Mar 2025
Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience

Marking a new era of uncovering the potential of NAD+ with precision science, ChromaDex evolves into Niagen Bioscience

  • Niagen Bioscience
  • 19 Mar 2025
12th Annual PANAGORA Pharma CX Summit 2025

Most Popular
April   2025
M T W T F S S
  1 2 3 4 5 6
7 8 9 10 11 12 13
14 15 16 17 18 19 20
21 22 23 24 25 26 27
28 29 30        

User Area

Discover

Engage with Us

© 2024 Pharmaceutical Era — A product of HISSM. All Rights Reserved.